Graf Akcie EVH (Evolent Health Inc). Diskuze k akciím EVH. Aktuální informace EVH.

Základní informace o společnosti Evolent Health Inc (Akcie EVH)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.61B
Hodnota podniku (EV) 2.28B
Tržby 973.644M
EBITDA 16.94M
Zisk -70.89
Růst v tržbách Q/Q -6.95 %
Růst v tržbách Y/Y 3.30 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.48
EV/Sales 2.34
EV/EBITDA 134.44
EV/EBIT N/A
PEG N/A
Price/Sales 2.62
P/FCF N/A
Price/Book 4.11
Účetní hodnota na akcii 7.29
Hotovost na akcii 4.22
FCF vůči ceně -5.07 %
Počet zaměstnanců 2,900
Tržba na zaměstnance 335.739k
Profit margin -32.69 %
Operating margin -4.24 %
Gross margin 22.80 %
EBIT margin -4.29 %
EBITDA margin 1.74 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -33.33 %
EPS - Očekávaný růst příští rok 0.00 %
Return on assets -5.29 %
Return on equity -11.43 %
ROIC -21.63 %
ROCE -4.69 %
Dluhy/Equity 1.21
Čistý dluh/EBITDA 2.50
Current ratio 1.25
Quick Ratio 1.25
Volatilita 4.67
Beta 1.21
RSI 53.90
Cílová cena analytiků 16
Známka akcie (dle analytiků) 1.82
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 87.268M
Procento shortovaných akcií 9.72 %
Short ratio 17.53 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie EVH

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$846.383$627.063$434.95$254.188$96.878-$25.671
Cost Of Goods Sold$513.059$327.825$269.352$155.177$57.398-$30.018
Gross Profit$333.324$299.238$165.598$99.011$39.48-$-4.347
Research And Development Expenses-------
SG&A Expenses$257.046$235.418$205.67$160.692$75.286-$15.6
Other Operating Income Or Expenses$-122.177$-66.785$-0.4$2.086---
Operating Expenses$1,152.995$674.543$507.79$491.607$139.85-$46.826
Operating Income$-306.612$-47.48$-72.84$-237.419$-42.972-$-21.155
Total Non-Operating Income/Expense$-20.504$-6.671$-3.564$-0.114$386.261$-25.246$41.186
Pre-Tax Income$-327.116$-54.151$-76.404$-237.533$343.289$-25.246$20.031
Income Taxes$-21.536$0.04$-6.637$-10.755$23.475-$0.008
Income After Taxes$-305.58$-54.191$-69.767$-226.778$319.814$-25.246$20.023
Other Income-------
Income From Continuous Operations$-305.58$-54.191$-69.767$-226.778$319.814$-25.246$20.023
Income From Discontinued Operations-------
Net Income$-301.971$-52.658$-60.665$-159.742$330.31$-31.137$2.418
EBITDA$-30.806$2.193$-39.558$-59.595$-35.806-$-19.947
EBIT$-306.612$-47.48$-72.84$-237.419$-42.972-$-21.155
Basic Shares Outstanding827764452521
Shares Outstanding827764454623
Basic EPS$-3.67$-0.68$-0.94$-3.55$13.14$-13.46$2.51
EPS - Earnings Per Share$-3.67$-0.68$-0.94$-3.55$6.93$-13.46$0.99
# 2020 2019 2018 2017 2016 2015
Current Ratio1.18691.81162.84992.00823.0999-
Long-term Debt / Capital0.24020.15670.1040.1165--
Debt/Equity Ratio0.31610.18580.1160.1319--
Gross Margin39.382247.720638.072938.951940.7523-
Operating Margin-36.2262-7.5718-16.7468-93.4029-44.3568-
EBIT Margin-36.2262-7.5718-16.7468-93.4029-44.3568-
EBITDA Margin-3.63970.3497-9.0948-23.4452-36.9599-
Pre-Tax Profit Margin-38.6487-8.6357-17.5662-93.4478354.3519-
Net Profit Margin-35.6778-8.3976-13.9476-62.844340.9546-
Asset Turnover0.5650.36410.33130.21190.0954-
Inventory Turnover Ratio------
Receiveable Turnover11.18567.8188.88616.25544.7533-
Days Sales In Receivables32.631246.687441.075258.349676.788-
ROE - Return On Equity-32.8918-4.5563-6.6679-24.862934.22011218.436
Return On Tangible Equity-629.7512-62.8696-39.4478-851.8421196.77961219.614
ROA - Return On Assets-20.399-3.1465-5.3148-18.900731.4928-67.8601
ROI - Return On Investment-24.9919-3.8423-5.9747-21.966234.22011219.614
Book Value Per Share10.983114.440613.52213.426515.836-0.5115
Operating Cash Flow Per Share-0.25080.16750.3541-0.3883-0.40034.5612
Free Cash Flow Per Share-0.17080.08880.2662-0.5919-0.54158.0546